Ken Yamazumi
Directeur/Membre du Conseil chez SanBio, Inc.
Profil
Ken Yamazumi is currently the Director & External Auditor at SanBio, Inc. He was previously the Chairman & President at Kirin Pharma Co. Ltd.
from 2007 to 2008, and the Representative Director & Executive Vice President at Kyowa Kirin Co., Ltd.
from 2011 to 2012.
Mr. Yamazumi received his undergraduate degree from the University of Tokyo in 1973.
Postes actifs de Ken Yamazumi
| Sociétés | Poste | Début |
|---|---|---|
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ken Yamazumi
| Sociétés | Poste | Fin |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Directeur/Membre du Conseil | 22/03/2012 |
Kirin Pharma Co. Ltd.
 Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Président | 06/10/2008 |
Formation de Ken Yamazumi
| University of Tokyo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Kirin Pharma Co. Ltd.
Kirin Pharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Kirin Pharma Co. Ltd. manufactures and sells pharmaceutical products. Its products include Nesp, Regpara Tablets, Espo, Phosblock and Gran. The company was founded in 2007 and is headquartered in Tokyo, Japan | Health Technology |
SanBio, Inc.
SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Health Services |
